1-(4-Hydroxynaphthalen-1-yl)ethanone, 95%, 250mg

((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate, 97%, 5g

tert-Butyl-4-aminobenzoate, 95.0%, 5g

Membrane de transfert ROTI®NC 0.2, 10 × 10 cm, 10 Pièce(s)

Violet de tétrazolium, pour la microscopie, 10 g, conditionnement en verre

QUINOXALINE-2,3-DICARBOXYLIC ACID, 95%, 1g

ETHYL 4-AMINO-3,5-DIBROMOBENZOATE, 95.0%, 100mg

2-BROMO-4-CYCLOBUTOXY-6-FLUOROBENZONITRILE, 95.0%, 250mg

ethyl 5-(3,4-dimethoxyphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 1g

Methyl 4-(cyanomethyl)benzoate, 95.0%, 1g

6-Methyl-1H-indole-5-carboxamide, 97.0%, 1g

2-PENTYLAMINE, 97.0%, 1g

azocane, 97.0%, 250mg